Opendata, web and dolomites


A slow release insemination that doubles the success rate of the most common first line treatment of infertility.

Total Cost €


EC-Contrib. €






Project "EVIE 2.0" data sheet

The following table provides information about the project.


Organization address
address: 37 HAHASHMONAIN ST.
city: RA ANANA
postcode: 4325623
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-02-29


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FERTILIGENT LTD IL (RA ANANA) coordinator 50˙000.00


 Project objective

Infertility impacts 25 million European citizens and 90 million couples globally (1 in 6 couples). Europe’s total fertility rate is among the lowest in the world, at 1.5 children per woman, a figure that is expected to decrease further to 1.2 by 2030 – making it a critical public health issue. Typically, infertility is treated with intrauterine insemination (IUI) or IVF. IUI is the most common first-line treatment as it is non-invasive and relatively cheap, but its success rate of around 7% means that IVF, a far more expensive and invasive procedure, with an overall success rate of around 30% becomes necessary. The market needs an affordable, easily accessible, non-invasive alternative that increases the success rate. EVIE 2.0 is a patent protected, fully automatic slow release insemination device that bypasses the hostile cervix to slowly release sperm into the uterus over four hours via a proprietary balloon catheter and an insemination syringe. Unlike standard Intrauterine Insemination (IUI), EVIE mimics nature by slowly and gently releasing the sperm - maximizing the opportunity for the sperm to reach the egg and increasing the prospect of fertilization - more than doubling the success rate of 7.2% to 18.7% and decreasing the average cost per pregnancy. EVIE 2.0 will transform the infertility market by providing an alternative non-invasive first-line treatment solution with increased success rate, reducing the need for couples to resort to expensive and complex treatments. To have EVIE 2.0 fully projected at a European and global level we need a further investment of €2.5M to complete all product development, scale-up and complete a clinical study. The proposed work in Phase 1 of the SME instrument fits into our overall plan to reach the market by contributing the financial resources needed to plan a fast, sound and widee deployment of EVIE 2.0.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EVIE 2.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EVIE 2.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More  

HAC (2019)


Read More